Publication

Back to overview

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.

Type of publication Peer-reviewed
Publikationsform Original article (peer-reviewed)
Author Béguelin Charles, Friolet Nicole, Moradpour Darius, Sahli Roland, Suter-Riniker Franziska, Lüthi Alexander, Cavassini Matthias, Günthard Huldrych F, Battegay Manuel, Bernasconi Enos, Schmid Patrick, Calmy Alexandra, Atkinson Andrew, Rauch Andri, Wandeler Gilles, Swiss HIV Cohort Study,
Project Swiss HIV Cohort Study (SHCS)
Show all

Original article (peer-reviewed)

Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume (Issue) 64(9)
Page(s) 1275 - 1278
Title of proceedings Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DOI 10.1093/cid/cix125

Open Access

URL https://boris.unibe.ch/96079/
Type of Open Access Repository (Green Open Access)

Abstract

We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.
-